An acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves’ disease

Given the immune background, we hypothesize that active Grave's hyperthyroidism is a risk factor for an acute phase reaction associated with the use of bisphosphonates. We recommend that in patients with Graves’ thyrotoxicosis and hypercalcemia, consider the risk of an acute phase reaction if p...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Katharine, Estrella, Jane, Rajagopal, Rohit, Shanmugalingam, Praseetha, Simmons, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538055/
https://www.ncbi.nlm.nih.gov/pubmed/28781829
http://dx.doi.org/10.1002/ccr3.1022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538055/
https://www.ncbi.nlm.nih.gov/pubmed/28781829
http://dx.doi.org/10.1002/ccr3.1022

Ejemplares similares